Stille

Stille EBITDA per Share

The EBITDA per Share of Stille (STIL.ST) as of Oct 24, 2026 is 8.10 SEK. In the previous year, EBITDA per Share was 9.41 SEK — a change of -13.91% (lower).

EBITDA per Share

8.10SEK

YoY

-13.91%

Last updated:

EBITDA per Share of Stille is 2025 8.10 SEK. EBITDA per Share of Stille was 2024 9.41 SEK. It decreases by -13.91% lower compared to the previous year.

The Stille EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
5.23 SEK
Jan 1, 2019
6.06 SEK
Jan 1, 2020
2.40 SEK
Jan 1, 2021
4.30 SEK
Jan 1, 2022
6.81 SEK
Jan 1, 2023
8.93 SEK
Jan 1, 2024
9.41 SEK
Jan 1, 2025
8.10 SEK
The Stille EBITDA per Share history
YEAREBITDA per ShareYoY
8.10SEK-13.91%
9.41SEK+5.30%
8.93SEK+31.11%
6.81SEK+58.45%
4.30SEK+78.92%
2.40SEK-60.32%
6.06SEK+15.78%
5.23SEK+35.65%
3.86SEK+13.95%
3.38SEK+62.14%
2.09SEK+784.69%
0.24SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

EBITDA per Share of Stille is 8.10 SEK in 2025.

EBITDA per Share of Stille changed from 9.41 SEK to 8.10 SEK, representing a -13.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Stille since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Stille

All Key Metrics — Stille